Subscribe to our newsletter

VisiVite needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at anytime.

Recent Articles

More like this

FDA approves new anti-vitreal therapy for wet AMD

The FDA recently announced its approval of BYOOVIZ™ as a treatment for wet age-related macular degeneration making the drug the first ophthalmology biosimilar to gain FDA approval in the United States. Biosimilar drugs are very close in structure [...]

Intravitreal injections increase likelihood of cataract surgery complication

Researchers recently shared results of a retrospective study of cataract surgery patient charts from the Hospital Universitario de la Princesa in Madrid, Spain. Researchers were looking for a possible link between intravitreal injections and [...]

Heart failure linked to age-related macular degeneration

A recent study took a look at the connection between heart failure and age-related macular degeneration (AMD) and was published in the Journal of the American Heart Association.

New imaging can detect early signs of Geographic Macular Degeneration

Study findings were recently posted in Progress in Retinal Eye Research that found that Detection of Apoptosis in Retinal Cells (DARC) imagining technology is able to identify areas of the eye that are showing signs of geographic atrophy (GA).

Aflibercept injections help diabetic retinopathy

A recent clinical trial study found that intravitreal injections of aflibercept (Eylea) reduced the severity of diabetic retinopathy as well as the threat of losing vision in patients with the disease.

Povidone-iodine eye drops possible dry eye therapy

A study recently published in the Journal of Ocular Pharmacology and Therapeutics found that 0.6% povidone-iodine (PVI) drops helped relieve symptoms of dry eye in patients suffering from damaged ocular surfaces.

New genetic test better at diagnosing glaucoma

Australian researchers have developed a genetic test for glaucoma that can identify 15 times more people at high risk for glaucoma when compared to the genetic test that is currently used.

Glaucoma patients more likely to report cost-related nonadherence

A recent study published in Ophthalmology Glaucoma revealed that glaucoma patients are more likely to report cost-related nonadherence compared to patients who do not have glaucoma.

Nasal spray for dry eye symptoms?

In the continually evolving field of dry eye therapies, next up is a nasal spray to address dry eye symptoms.
More recent articles
WANT SOMETHING AMAZING?

Ultimate insiders Guide to Eye Health

Newly updated popular book by Dr. Paul Krawitz - now available as a FREE DOWNLOAD. Includes AREDS2 study results and explanations, the 'Ultimate Insider's Guide to Eye Health" contains critical information about common eye problems, including macular degeneration, dry eye syndrome, cataract surgery, diabetic retinopathy, and contact lenses.

Get this ebook now